These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18608028)

  • 41. The selection and design of control conditions for randomized controlled trials of psychological interventions.
    Mohr DC; Spring B; Freedland KE; Beckner V; Arean P; Hollon SD; Ockene J; Kaplan R
    Psychother Psychosom; 2009; 78(5):275-84. PubMed ID: 19602916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical trials and P values.
    Cooke RW; Weindling AM
    Pediatrics; 1993 Jul; 92(1):188-9. PubMed ID: 8516078
    [No Abstract]   [Full Text] [Related]  

  • 43. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial.
    Wilkinson HA
    Neurosurgery; 2008 Aug; 63(2):E376; author reply E376. PubMed ID: 18797322
    [No Abstract]   [Full Text] [Related]  

  • 44. Maximising recruitment into randomised controlled trials: the role of multidisciplinary cancer teams.
    McNair AG; Choh CT; Metcalfe C; Littlejohns D; Barham CP; Hollowood A; Falk SJ; Blazeby JM
    Eur J Cancer; 2008 Nov; 44(17):2623-6. PubMed ID: 18804999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anesthesia and outcome after neonatal surgery: the role for randomized trials.
    Davidson AJ; McCann ME; Morton NS; Myles PS
    Anesthesiology; 2008 Dec; 109(6):941-4. PubMed ID: 19034085
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How to perform a critical analysis of a randomised controlled trial.
    Estellat C; Torgerson DJ; Ravaud P
    Best Pract Res Clin Rheumatol; 2009 Apr; 23(2):291-303. PubMed ID: 19393572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Importance of randomization in early clinical trials.
    Sargent D
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):249-51. PubMed ID: 19521327
    [No Abstract]   [Full Text] [Related]  

  • 49. [Role of the methodology in cluster randomized trials].
    Kramar A; Bonnetain F; Mathoulin-Pélissier S
    Bull Cancer; 2008 Dec; 95(12):1141-2. PubMed ID: 19108340
    [No Abstract]   [Full Text] [Related]  

  • 50. The design and interpretation of pilot trials in clinical research in critical care.
    Arnold DM; Burns KE; Adhikari NK; Kho ME; Meade MO; Cook DJ;
    Crit Care Med; 2009 Jan; 37(1 Suppl):S69-74. PubMed ID: 19104228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Validus Medicus and a new gold standard.
    Ziliak ST
    Lancet; 2010 Jul; 376(9738):324-5. PubMed ID: 20681063
    [No Abstract]   [Full Text] [Related]  

  • 52. Implications of new diabetes treatment trials: should current clinical practice be altered?
    Kravetz JD; Federman DG
    Postgrad Med; 2009 May; 121(3):67-72. PubMed ID: 19491542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Office based non-oncology urology trials.
    Casey RW; Barkin J
    Can J Urol; 2008 Aug; 15(4):4219-22. PubMed ID: 18706155
    [No Abstract]   [Full Text] [Related]  

  • 54. Fallacies in clinical cardiovascular trials.
    Swedberg K
    Heart; 2009 Sep; 95(17):1464-8. PubMed ID: 19684197
    [No Abstract]   [Full Text] [Related]  

  • 55. Minimizing and accounting for the impact of rescue therapies in clinical trials.
    Fergusson DA; Ramsay T
    Pediatr Crit Care Med; 2009 Jul; 10(4):524-5. PubMed ID: 19584638
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapy and clinical trials.
    Krasuski RA
    Curr Opin Lipidol; 2008 Oct; 19(5):550-1. PubMed ID: 18769241
    [No Abstract]   [Full Text] [Related]  

  • 57. [Statistical data as scientific cosmetics].
    Taube A
    Lakartidningen; 1997 Jun; 94(23):2157. PubMed ID: 9213674
    [No Abstract]   [Full Text] [Related]  

  • 58. Designing phase III or IV trials for vaccines: choosing between individual or cluster randomised trial designs.
    Vaucher P
    Vaccine; 2009 Mar; 27(13):1928-31. PubMed ID: 19368773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized clinical trials in orthodontics: reality, dream, or nightmare?
    Zuccati G; Clauser C; Giorgetti R
    Am J Orthod Dentofacial Orthop; 2009 Nov; 136(5):634-7. PubMed ID: 19892277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incorporating cost in power analysis for three-level cluster-randomized designs.
    Konstantopoulos S
    Eval Rev; 2009 Aug; 33(4):335-57. PubMed ID: 19509118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.